Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT02002923
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Registry
-
NCT02002923
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT02002923. Randomized; double masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Procedure)
- Pulmonary vein isolation
- Intervention (Drug)
- Botulinum Toxin
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
Record details
- Record id
cardio:ct-nct02002923- Content hash
b8e4e79d5446e10c15acb70b08198547d134ffe57fbd38a0bfc2c687a870006f